STOCK TITAN

C3.Ai, Inc. Form 4 Filings

AI NYSE

Every Form 4 that C3.Ai, Inc. (AI) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow AI and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full AI filings page.

Rhea-AI Summary

C3.ai, Inc. (AI) reported several equity transactions by CEO, Chairman and 10% owner Thomas M. Siebel. On September 1, 2026, 32,736 Restricted Stock Units vested and were settled into 32,736 shares of Class A Common Stock.

On September 2, 2026, 16,890 shares were automatically withheld and sold by the issuer at a weighted-average price between $10.30 and $10.31 per share to satisfy tax withholding obligations. On September 3, 2026, Siebel made a bona fide gift of 15,846 directly held shares and an associated 15,846-share acquisition by The Siebel Living Trust, where he is trustee, was reported as indirect ownership. No Rule 10b5-1 trading plan is reported.

Rhea-AI Summary

C3.ai, Inc. (AI) reported that director John Charles Dwyer received a grant of 132,077 options to purchase Class A common stock on August 25, 2026. The options have an exercise price of $9.79 per share and expire on August 24, 2036, leaving him with 132,077 derivative securities held directly after the grant.

Vesting is performance- and service-based: beginning with the vesting commencement date of August 25, 2026, 5% of the option shares vest on the last day of each fiscal quarter that he remains a director and attends the regularly scheduled board meeting in person. Any quarterly portion that does not vest due to a missed meeting becomes “Suspended Shares” and vests only after the fifth anniversary of the vesting commencement date, if the attendance conditions are satisfied in subsequent periods.

Rhea-AI Summary

C3.ai, Inc. CEO and Chairman Thomas M. Siebel exercised a stock option for 453,314 shares of Class A Common Stock at an exercise price of $3.90 per share on August 11, 2026, then sold 453,314 shares at a weighted-average price of $10.51 per share. The option was reported as fully vested and had an expiration date of November 27, 2028. After the exercise, 2,413,196 stock options remained reported as held directly. The activity was effected under a previously established Rule 10b5-1 trading plan dated September 20, 2024. Additional Class A Common Stock is reported as held indirectly through various trusts, LLCs and limited partnerships associated with Siebel.

Rhea-AI Summary

C3.ai, Inc. chief financial officer Hitesh Lath sold 20,000 shares of Class A Common Stock under a previously established Rule 10b5-1 trading plan. The shares were sold at a weighted-average price of $10 per share, with trades between $10 and $10.015, leaving him holding 363,106 shares directly.

Rhea-AI Summary

C3.ai, Inc. CEO Thomas M. Siebel reported several equity moves. On August 2, he exercised 283,334 Performance Restricted Stock Units into the same number of Class A shares. On August 3, 139,500 shares were automatically sold by the issuer at a weighted-average $9.61 to satisfy his tax withholding obligations. On August 4, he made a bona fide gift of 143,834 shares, which are held in a living trust where he serves as trustee, and he also continues to hold additional shares indirectly through affiliated entities.

Rhea-AI Summary

C3.ai, Inc. director John E. Hyten reported a disposition to the issuer of 2,500 shares of Class A Common Stock on July 15, 2026 at $9.14 per share. A footnote states that 2,500 of 5,000 Restricted Stock Units that vested that day were settled in cash. Following the transaction, Hyten holds 69,214 shares directly and 146,830 shares indirectly through Hyten Group LLC, where he is the manager and sole member.

Rhea-AI Summary

C3.ai, Inc. CEO and Chairman Thomas M. Siebel reported option exercises and related stock sales in Class A Common Stock. Over July 14–15, 2026, he exercised options for 462,565 shares at strike prices of $3.90 and $2.04, and sold the same number of shares in open-market transactions at line-item prices of $9.07, $9.31 and $9.32 per share, with individual trades occurring between $8.83 and $9.60. The sales were effected under a previously established Rule 10b5-1 trading plan dated September 20, 2024. After these transactions, he holds 722,362 shares directly, additional indirect positions through several investment entities and a family trust, and retains stock options for 2,866,510 shares at a $3.90 exercise price expiring November 27, 2028, and 64,975 shares at a $2.04 exercise price expiring November 7, 2027.

Rhea-AI Summary

C3.ai, Inc. Chief Executive Officer Stephen Bradley Ehikian reported several equity transactions involving Class A Common Stock. He received a fully vested grant of 27,503 Restricted Stock Units (RSUs), each representing one share upon settlement. To cover tax withholding obligations related to vested RSUs, 50,542 shares were automatically withheld and sold by the issuer at a weighted-average price of $9.45 per share. He also made two bona fide gifts totaling 88,756 shares, including one transfer from the Stephen Bradley Ehikian Revocable Trust, where he is sole trustee. After these moves, he directly holds 606,752 shares and indirectly holds 274,182 shares through the trust.

Rhea-AI Summary

C3.ai, Inc. Chief Financial Officer Hitesh Lath reported a mix of equity awards and share sales involving Class A Common Stock. He received two grants totaling 198,619 Restricted Stock Units (RSUs), including one award of 100,000 RSUs that will vest on September 15, 2027 with the remainder vesting over the following 12 months, subject to continued service.

He also reported the sale of 48,619 shares at a weighted-average price of $8.77 per share, with the filing noting these shares were automatically sold by the issuer to cover tax withholding obligations related to RSU vesting and were executed under a previously established Rule 10b5-1 plan. Following these transactions, Lath holds 383,106 shares of Class A Common Stock directly.

Rhea-AI Summary

C3.ai, Inc. Chief Financial Officer Hitesh Lath reported RSU vesting, related share issuances, and a tax-related share sale. On June 15, 2026, he acquired a total of 29,008 shares of Class A Common Stock through the conversion of restricted stock units at a price of $0.00 per share. Each RSU represents a contingent right to receive one share of Class A Common Stock upon settlement.

On June 16, 2026, 34,210 shares of Class A Common Stock were sold at a weighted-average price of $10.95 per share. According to the disclosure, these shares were automatically withheld and sold by the issuer to satisfy Lath's tax withholding obligations related to the RSU vesting. Following these transactions, he directly holds 233,106 shares of Class A Common Stock.

Rhea-AI Summary

C3.ai, Inc. director John E. Hyten reported an insider transaction involving Class A Common Stock. On June 15, 2026, he disposed of 2,500 shares back to the issuer at $11.03 per share in a disposition to the company, not an open-market sale.

The filing notes that 5,000 Restricted Stock Units vested on that date, with 2,500 settled in cash. Following the transaction, Hyten holds 71,714 shares directly and 146,830 shares indirectly through Hyten Group LLC, where he is manager and sole member.

Rhea-AI Summary

C3.ai, Inc. CEO and Chairman Thomas M. Siebel reported a mix of stock sales, option exercises, RSU vesting and gifts of Class A Common Stock. He exercised stock options for 472,005 shares at $2.04 per share and 44,767 RSUs that converted into the same number of shares. On June 12–15, 2026, he sold 472,005 shares at a weighted-average price of about $11.11 and 23,570 shares at $10.92 per share, with a portion automatically sold by the issuer to satisfy tax withholding tied to RSU vesting under company policy. The filing notes that at least some sales were made under a previously established Rule 10b5-1 trading plan dated September 20, 2024. Siebel also made bona fide gifts totaling 42,394 shares, both from direct holdings and from a trust. After these transactions, he directly holds 722,362 shares, while entities and trusts associated with him hold several million additional shares reported as indirect ownership.

Rhea-AI Summary

C3.ai CEO and Chairman Thomas M. Siebel exercised stock awards and restructured his holdings in Class A Common Stock. On June 1, 2026, he exercised stock options for 6,166,667 shares at $11.16 per share and 32,736 RSUs, converting derivative awards into common stock.

The same day, all 6,166,667 option shares were removed from his remaining option balance, leaving no options from that grant outstanding. On June 2, 2026, 17,350 shares were sold at a weighted-average price of $11.32, with a footnote stating the issuer automatically sold these shares to cover tax withholding on RSU vesting.

On June 3, 2026, bona fide gifts totaling 12,364,106 shares were reported, involving both direct and indirect holdings. After these transactions, Siebel continues to hold 6,904,415 shares directly and 6,902,156 shares indirectly through entities such as trusts and partnerships.

Rhea-AI Summary

C3.ai, Inc. director John E. Hyten reported a routine compensation-related share disposition and updated holdings. On May 15, 2026, 2,500 shares of Class A Common Stock were disposed of back to the issuer at $8.65 per share, coded as a disposition to the issuer.

The filing notes that 5,000 Restricted Stock Units vested on that date and 2,500 of those units were settled in cash rather than shares. After the disposition, Hyten holds 74,214 shares directly and 146,830 shares indirectly through Hyten Group LLC, where he is the manager and sole member.

Rhea-AI Summary

C3.ai, Inc. CEO and Chairman Thomas M. Siebel reported paired option exercises and share sales in Class A Common Stock. On May 15 and May 18, 2026, he exercised options to acquire a total of 481,638 shares at $2.04 per share and sold the same number of shares in open-market transactions at weighted-average prices around $8.65–$8.72.

The filing shows he continues to hold 722,362 shares directly after these transactions, as well as additional indirect holdings through several trusts and investment entities referenced in the footnotes. The sales were executed under a previously established Rule 10b5-1 trading plan dated September 20, 2024, indicating they were pre-scheduled rather than discretionary market-timed trades.

Rhea-AI Summary

C3.ai Executive Chairman Thomas M. Siebel reported multiple share transactions involving Class A Common Stock. On May 1, 2026, he exercised 53,125 Restricted Stock Units (RSUs), converting them into the same number of common shares at a stated price of $0.00 per share, and the RSU derivative position was reduced to zero.

On May 4, 2026, 27,210 shares were sold at a weighted-average price of $9.27 per share. A footnote explains these shares were automatically withheld and sold by the issuer to satisfy Siebel’s tax withholding obligations related to the RSU vesting, indicating a mechanistic tax transaction rather than a discretionary open-market sale.

On May 5, 2026, Siebel made two bona fide gifts totaling 51,830 shares, with 25,915 shares transferred from indirect holdings through entities such as trusts and partnerships and 25,915 shares from his direct holdings. After these transactions, he continued to hold substantial direct and indirect positions, including 722,362 directly held shares and 720,103 shares held indirectly through a trust.

Rhea-AI Summary

C3.ai, Inc. director John E. Hyten reported a compensation-related share disposition tied to vested equity awards. On April 15, 2026, 2,500 shares of Class A Common Stock were disposed of to the issuer at $9.52 per share when 5,000 Restricted Stock Units vested and were partly settled in cash. After this, he held 76,714 shares directly and 146,830 shares indirectly through Hyten Group LLC, where he is manager and sole member.

Rhea-AI Summary

C3.ai, Inc. Executive Chairman Thomas M. Siebel reported option exercises and share sales in Class A Common Stock. On April 13 and 14, 2026, he exercised stock options to acquire a total of 491,467 shares at an exercise price of $2.04 per share.

He then sold 326,189 shares at a weighted-average price of $8.31 on April 13 and 165,278 shares at a weighted-average price of $8.49 on April 14 in open-market transactions. Following these transactions, his directly held Class A Common Stock position was 722,362 shares, and the filing also lists several indirect holdings through trusts and affiliated entities. The transactions were effected under a previously established Rule 10b5-1 trading plan dated September 20, 2024.

Rhea-AI Summary

C3.ai, Inc. Chief Executive Officer Stephen Bradley Ehikian reported several equity transactions in Class A Common Stock. He received a fully vested grant of 32,093 Restricted Stock Units, each representing one share. On a separate date, 52,194 shares were sold at a weighted-average price of $8.2211 per share to satisfy tax withholding obligations related to RSU vesting.

Ehikian also made bona fide gifts totaling 94,632 shares, split between his direct holdings and a revocable trust. Following these moves, he continues to hold 674,169 shares directly and 229,804 shares indirectly through the Stephen Bradley Ehikian Revocable Trust.

Rhea-AI Summary

C3.ai director John E. Hyten reported gifting Class A shares of the company. On March 31, 2026, he made two bona fide gift transfers totaling 87,888 shares of Class A Common Stock at a stated price of $0.00 per share.

Following these gifts, Hyten holds 79,214 Class A shares directly and 146,830 Class A shares indirectly. The indirect holdings are through Hyten Group LLC, where he is the manager and sole member. These are non-market, non-cash transactions rather than open-market sales.

Rhea-AI Summary

C3.ai, Inc. director Jim H. Snabe reported offsetting trades in Class A Common Stock. On March 27, he sold 10,000 shares in an open-market sale at $8.08 per share and purchased 10,000 shares in an open-market buy at $7.73 per share.

The footnotes state the sale was made to satisfy “exit tax” obligations related to his emigration from Denmark, and that the resulting short-swing profits of $3,509 were remitted to the company. Following these transactions, he holds 395,000 shares directly and 28,000 shares indirectly through BJHS Invest ApS, of which he is the sole member.

Rhea-AI Summary

C3.ai, Inc. Executive Chairman Thomas M. Siebel reported an exercise-and-sell transaction under a pre-established Rule 10b5-1 trading plan. On March 17–18, 2026, he exercised stock options for a total of 501,497 shares of Class A Common Stock at an exercise price of $2.04 per share, then sold the same number of shares in open-market transactions.

The reported sales were at weighted-average prices around $8.67 and $8.86, across price ranges disclosed in the filing. Following these transactions, he directly held 722,362 shares of Class A Common Stock, in addition to several indirect holdings through trusts and entities where he serves as trustee, general partner or chairman.

Rhea-AI Summary

C3.ai, Inc. Chief Financial Officer Hitesh Lath reported RSU vesting, share conversions, and a related tax sale. On March 15, 2026, he exercised restricted stock units to acquire a total of 29,008 shares of Class A Common Stock at a conversion price of $0.00 per share. Each RSU represents a contingent right to receive one share upon settlement. On March 16, 2026, 15,248 shares of Class A Common Stock were sold at a weighted-average price of $8.98 per share in multiple transactions, and were automatically withheld and sold by the issuer to satisfy tax withholding obligations from the RSU vesting. After these transactions, he directly holds 238,308 shares of Class A Common Stock.

Rhea-AI Summary

C3.ai, Inc. director John E. Hyten reported a compensation-related adjustment involving 2,500 shares of Class A common stock. The filing shows a code D disposition to the issuer, with a footnote explaining that 2,500 of 5,000 Restricted Stock Units vesting on March 15, 2026 were settled in cash. Following this transaction, Hyten holds 123,158 shares directly and 102,886 shares indirectly through Hyten Group LLC, where he is the manager and sole member.

Rhea-AI Summary

C3.ai Executive Chairman Thomas M. Siebel reported multiple equity moves involving the company’s Class A Common Stock. On March 11, 2026, he exercised 44,766 Restricted Stock Units, receiving the same number of common shares at a conversion price of $0.00 per share.

In connection with this vesting, 23,435 shares were automatically sold by the issuer on March 12, 2026 at a weighted-average price of about $9.11 per share to satisfy tax withholding obligations. On March 13, 2026, he made two bona fide gifts totaling 42,662 shares, split between his direct holdings and an entity reported as indirect ownership. Following these transactions, he holds 722,362 shares directly and continues to have additional indirect holdings through several trusts and entities, including 1,237,115 shares held by Siebel Asset Management III, L.P.

Rhea-AI Summary

C3.ai, Inc. director Jim H. Snabe reported an open-market purchase of 25,000 shares of Class A Common Stock at $9.00 per share on March 9, 2026. After this transaction, he directly holds 395,000 shares.

The filing also shows an additional 28,000 shares held indirectly through BJHS Invest ApS, an entity of which he is the sole member. This mix of direct and indirect holdings outlines his overall equity exposure to C3.ai following the reported trade.

Rhea-AI Summary

C3.ai, Inc. reported that Chief Financial Officer Hitesh Lath received a grant of options for 100,000 shares of common stock. The options were awarded at an exercise price of $0.00 per share. According to the vesting terms, 33.33% of the grant vests on the one-year anniversary of the vesting commencement date, with 8.33% vesting quarterly over the following two years, contingent on continued service.

Rhea-AI Summary

C3.ai, Inc. Executive Chairman Thomas M. Siebel reported several equity transactions involving the company’s Class A common stock and related equity awards. On March 1, 2026, he exercised 32,736 Restricted Stock Units, converting them into the same number of Class A shares at a stated price of $0.00 per share.

On March 2, 2026, Siebel sold 17,655 Class A shares in an open‑market transaction at a weighted‑average price of $7.79 per share, with individual trades ranging from $7.75 to $7.82. On March 3, 2026, he made bona fide gifts totaling 15,081 Class A shares from his direct holdings and an additional 15,081 shares from entities such as The Siebel Living Trust and affiliated investment vehicles, which hold shares associated with him.

Rhea-AI Summary

C3.ai director John E. Hyten reported a disposition of Class A common stock tied to equity compensation. On February 15, 2026, he disposed of 2,500 shares to the issuer at $10.78 per share, reflecting that 2,500 of 5,000 vested restricted stock units were settled in cash. After this transaction, he beneficially owned 125,658 Class A shares directly and 102,886 shares indirectly through Hyten Group LLC, where he is the manager and sole member.

Rhea-AI Summary

C3.ai Executive Chairman Thomas M. Siebel, a director and 10% owner, reported a planned stock transaction in Class A common shares. On February 10, 2026, he exercised stock options for 511,732 shares at an exercise price of $2.04 per share and then sold 511,732 shares in open-market transactions at a weighted-average price of $11.66 per share.

The filing shows he directly held 722,362 Class A shares afterward, plus additional indirect holdings through various entities, including The Siebel Living Trust, First Virtual Holdings LLC, Siebel Asset Management partnerships, and The Siebel 2011 Irrevocable Children's Trust. The activity was carried out under a pre-established Rule 10b5-1 trading plan dated September 20, 2024, and the exercised option was fully vested.

Rhea-AI Summary

C3.ai Executive Chairman Thomas M. Siebel, a director and 10% owner, reported RSU vesting, related share issuance, a tax-withholding sale, and internal transfers of Class A Common Stock. On February 1, 2026, 53,125 Restricted Stock Units vested and were settled into 53,125 shares of Class A stock at an exercise price of $0, increasing his direct holdings to 775,487 shares.

On February 2, 2026, 27,605 Class A shares were sold at a weighted-average price of $10.81, with the issuer automatically withholding and selling these shares to satisfy tax obligations tied to the RSU vesting. On February 3, 2026, 25,520 shares were transferred from direct ownership to The Siebel Living Trust u/a/d 7/27/93 and 25,520 shares were received by that trust, both at $0. Indirect holdings are also reported in several related entities, including The Siebel Living Trust, First Virtual Holdings, LLC, and Siebel Asset Management partnerships.

Rhea-AI Summary

C3.ai, Inc. director John E. Hyten reported a disposition of 2,500 shares of Class A Common Stock on January 15, 2026 related to restricted stock units settled in cash. The filing explains that 2,500 of 5,000 restricted stock units that vested on that date were settled in cash rather than in stock.

Following this transaction, Hyten held 128,158 shares of Class A Common Stock directly. In addition, 102,886 shares of Class A Common Stock were held indirectly through Hyten Group LLC, an entity of which he is the manager and sole member.

Rhea-AI Summary

C3.ai Executive Chairman Thomas M. Siebel reported option exercises and share sales of Class A common stock. On January 13, 2026, he exercised a stock option for 212,586 shares at an exercise price of $2.04 per share and acquired the same number of Class A shares.

That day, he sold 212,586 Class A shares directly at a weighted-average price of $13.52 per share and a further 309,589 shares indirectly through an entity associated with him, in multiple trades between $13.265 and $14.20. The activity was carried out under a previously established Rule 10b5-1 trading plan dated September 20, 2024. Following these transactions, he continued to hold both direct and indirect positions in C3.ai stock, including option holdings that remain outstanding and fully vested.

Rhea-AI Summary

C3.ai, Inc. Chief Executive Officer Stephen Bradley Ehikian reported several equity transactions in the company’s Class A common stock. On 12/30/2025, he received a grant of 18,090 Restricted Stock Units (RSUs), each representing one share of Class A common stock, which the filing states are fully vested. On 12/31/2025, 234,918 shares of Class A common stock were automatically withheld and sold by the company to cover his tax withholding obligations related to vested RSUs, at a weighted-average price of $13.56 per share.

Following these transactions, the filing shows changes in how his holdings are structured. On 01/02/2026, 182,488 shares moved from his direct ownership at no stated price, and the same number of shares were then listed as indirectly owned through the Stephen Bradley Ehikian Revocable Trust, for which he is the sole trustee. After the reported transactions, he beneficially owned 924,074 shares directly and 182,488 shares indirectly through the trust.

Rhea-AI Summary

C3.ai, Inc. Executive Chairman, director and 10% owner Thomas M. Siebel reported selling Class A common stock in mid-December 2025. On December 16, 2025, he sold 392,064 shares at a weighted-average price of $14.37, and on December 17, 2025, he sold 140,768 shares at a weighted-average price of $14.22. The filing states these transactions were made under a pre-established Rule 10b5-1 trading plan dated September 20, 2024.

Following these transactions, Siebel continues to beneficially own significant amounts of C3.ai stock, including indirect holdings through The Siebel Living Trust and several affiliated entities such as First Virtual Holdings, Siebel Asset Management partnerships, and The Siebel 2011 Irrevocable Children's Trust.

Rhea-AI Summary

C3.ai, Inc. reported an insider equity transaction by one of its directors. On December 15, 2025, the director disposed of 2,500 shares of Class A common stock at $14.65 per share in a transaction linked to restricted stock units. A footnote explains that 2,500 of 5,000 restricted stock units that vested on that date were settled in cash rather than in shares.

Following this transaction, the director beneficially owned 130,658 Class A shares directly and 102,886 Class A shares indirectly through The Hyten Group LLC, where the reporting person is the manager and sole member.

Rhea-AI Summary

C3.ai’s Chief Financial Officer reported equity compensation activity involving the company’s Class A common stock. On December 15, 2025, restricted stock units (RSUs) converted into 8,008, 1,000 and 20,000 shares at an exercise price of $0, increasing the officer’s direct holdings.

On December 16, 2025, 15,042 shares were automatically sold at a weighted-average price of $14.38 to satisfy tax withholding obligations related to the RSU vesting. After these transactions, the officer directly owned 223,120 Class A shares and continued to hold RSUs that vest over time as service with the company continues.

Rhea-AI Summary

C3.ai, Inc. reported that a company director received a grant of stock options covering 34,091 shares of Class A common stock at an exercise price of $15.92 per share.

The options were granted on December 11, 2025 and are scheduled to vest in 12.5% installments at the end of each fiscal quarter from the vesting commencement date until the second anniversary, if the director remains on the board and attends the regularly scheduled board meetings in person during each quarter.

Any quarterly portion that does not vest because the director misses a regularly scheduled meeting is suspended and can vest only after the second anniversary if later attendance requirements are met, and the options expire on December 10, 2035.

Rhea-AI Summary

C3.ai, Inc. executive chairman, director and 10% owner Thomas M. Siebel reported multiple equity transactions in December 2025. On 12/11/2025, 44,767 restricted stock units vested into Class A common stock and he received a new grant of 722,362 RSUs, which vest 33% on December 11, 2026 and then quarterly. On 12/12/2025, 23,000 shares were sold at a weighted-average price of $15.94 to cover tax withholding obligations linked to the RSU vesting.

On the same date, he also received a stock option to buy 1,133,474 Class A shares at an exercise price of $17.512 per share, vesting in three equal annual installments starting December 11, 2026 and expiring on December 10, 2035. Following these transactions, he reports 722,362 shares held directly and additional indirect holdings through family trusts and investment entities.

Rhea-AI Summary

C3.ai, Inc. insider Thomas M. Siebel, Executive Chairman, director and 10% owner, reported several equity transactions in Class A common stock. On 12/01/2025, 32,736 shares were acquired upon the vesting and settlement of restricted stock units, with a matching reduction in RSUs reported as an exercise (code M). On 12/02/2025, 17,000 shares were sold (code S) at a weighted-average price of $14.21, with the company’s explanation stating these sales were automatically made to cover tax withholding on the RSU vesting. On 12/03/2025, 15,736 shares were transferred as gifts (code G) from direct ownership to indirect ownership at zero price. Following these transactions, Siebel reports direct ownership of Class A common stock and substantial indirect holdings through multiple entities and trusts, as well as 130,946 RSUs that remain outstanding and unexercised.

Rhea-AI Summary

C3.ai (AI) reported an insider transaction by an Executive Chairman who is also a Director and 10% Owner. On 11/11/2025, the reporting person sold 543,706 shares of Class A Common Stock under a previously established Rule 10b5-1 trading plan dated September 20, 2024.

The reported weighted-average price was $15.24, with individual trades executed between $14.91 and $15.59. Following the sale, beneficial ownership includes 1,437,174 shares held indirectly by a trust, plus additional indirect holdings of 9,216, 170,294, 72,695, and 1,237,115 shares through related entities, as noted in the footnotes.

Rhea-AI Summary

C3.ai (AI) disclosed insider transactions by its Executive Chairman. On 11/01/2025, the reporting person converted 53,125 RSUs into Class A shares. On 11/03/2025, 27,545 shares were sold at a weighted-average $17.30 to satisfy tax withholding, with trades ranging $17.19–$17.37. On 11/04/2025, 25,580 shares were transferred as a gift at $0, moving from direct to indirect ownership via a family trust.

Following these transactions, indirect holdings include 1,980,880 shares held by The Siebel Living Trust and additional stakes through affiliated entities. Derivative holdings show 106,250 RSUs remaining after the vesting.

Rhea-AI Summary

C3.ai (AI) reported an insider transaction by its Executive Chairman (also a Director and 10% Owner). On 10/14/2025, the reporting person sold 554,802 Class A shares at a weighted-average price of $18.82, pursuant to a Rule 10b5-1 trading plan dated September 20, 2024. The sales occurred within a price range of $18.39 to $19.35.

Following the transaction, beneficial ownership includes 1,955,300 shares held by The Siebel Living Trust and 1,237,115 shares held by The Siebel 2011 Irrevocable Children's Trust, with additional indirect holdings noted.

Rhea-AI Summary

Stephen M. Ward Jr., a director of C3.ai, Inc. (AI), reported an acquisition on 10/03/2025 of a stock option covering 30,264 shares of Class A common stock with an exercise price of $19.16. Following the reported transaction the filing shows 30,264 shares beneficially owned directly. The option includes a time‑based vesting schedule that begins on 10/03/2025 (the Vesting Commencement Date): 12.5% of the optioned shares vest on the last day of each fiscal quarter while the director remains a board member and attends each regularly scheduled in‑person board meeting during the two years after the Vesting Commencement Date. Missed meetings suspend quarterly vesting; suspended shares may vest later if attendance requirements are subsequently met. The option appears to expire on 10/02/2035.

Rhea-AI Summary

Sridhar KR, a director of C3.ai, Inc. (AI), reported an award of 28,628 stock options on 10/03/2025. The options carry an exercise price of $19.16 and, following the reported grant, the reporting person beneficially owns 28,628 shares on a direct basis. The option term references an expiration/related date of 10/02/2035.

The award vests on a quarterly schedule: 12.5% of shares subject to the option vest on the last day of each regularly scheduled board meeting quarter while the director remains in attendance, measured from the Vesting Commencement Date of 10/03/2025 until the two‑year anniversary. Any quarterly shares missed for failure to attend are labeled as "Suspended Shares" and will vest only after the two‑year anniversary if attendance requirements are later met. The Form 4 is signed via attorney‑in‑fact on 10/07/2025.

Rhea-AI Summary

C3.ai, Inc. (AI) reported a Form 4 filing showing that director D. Bruce Sewell was granted 30,264 stock options on 10/03/2025 with an exercise price of $19.16 per share. The options are exercisable through 10/02/2035 and are held directly by the reporting person.

The awards vest on a quarterly schedule starting on the Vesting Commencement Date of 10/03/2025, with 12.5% of the option shares vesting on the last day of each fiscal quarter for two years, subject to the director’s in-person attendance at regularly scheduled board meetings. Missed meetings suspend vesting for the affected quarterly tranche until attendance requirements are later satisfied. The report was signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Summary

Alan S. Murray, a director of C3.ai, Inc. (AI), reported acquiring a stock option to purchase 28,628 shares of Class A common stock with an exercise price of $19.16 on 10/03/2025. The option was reported as an acquisition and shows 28,628 shares underlying the option with a stated exercisability/expiration entry of 10/02/2035. Vesting is time- and attendance-based: starting on the Vesting Commencement Date of 10/03/2025, 12.5% of the optioned shares vest at the end of each fiscal quarter while the reporting director attends regularly scheduled quarterly board meetings, through a two-year period. Any quarterly vesting missed for lack of attendance becomes suspended and will only vest after the second anniversary if attendance requirements are later met. The form is signed by an attorney-in-fact on 10/07/2025.

Rhea-AI Summary

Condoleezza Rice, a director of C3.ai, Inc. (AI), reported transactions on 10/03/2025 affecting both Class A common stock and stock options. The filing shows a sale of 312 Class A shares at $1.86, leaving 74,699 Class A shares beneficially owned directly after the sale. An additional 587 shares are held indirectly in a trust where she is trustee.

The report also discloses two option transactions dated 10/03/2025: a fully vested option for 312 shares (exercise price $1.86) and an acquisition of an option for 28,628 shares at an exercise price of $19.16 that vests quarterly over up to two years conditioned on in-person board meeting attendance, with a final exercisability/expiration schedule extending to 10/02/2035.

Rhea-AI Summary

C3.ai filed a Form 4 reporting a director stock option for 32,309 shares of Class A common stock at an exercise price of $19.16, granted on October 3, 2025. The option expires on October 2, 2035.

Vesting begins October 3, 2025: 12.5% of the option vests on the last day of each fiscal quarter in which the director attends the regularly scheduled board meeting in person over two years. Any quarter missed suspends that tranche; suspended tranches vest only after the second anniversary if subsequent attendance requirements are met.

Rhea-AI Summary

Director Jim H. Snabe received a stock option award for 28,628 shares of Class A common stock with an exercise price of $19.16. The option was granted on 10/03/2025 and has an expiration/exercise term tied to an expiration date of 10/02/2035. The award vests in 12.5% increments on the last day of each regularly scheduled quarterly board meeting starting on the vesting commencement date of 10/03/2025, subject to in-person attendance; any quarterly vesting missed will be suspended and may vest only after the second anniversary if attendance requirements are later met. The Form 4 was filed as a report by one reporting person and signed by an attorney-in-fact on 10/07/2025.